These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 17166566)
1. Expression of CD40 and growth-inhibitory activity of CD40 ligand in ovarian cancer cell lines. Melichar B; Patenia R; Gallardo S; Melicharová K; Hu W; Freedman RS Gynecol Oncol; 2007 Mar; 104(3):707-13. PubMed ID: 17166566 [TBL] [Abstract][Full Text] [Related]
2. Expression of CD40 and growth-inhibitory activity of CD40 ligand in colon cancer ex vivo. Wu Y; Wang L; He X; Xu H; Zhou L; Zhao F; Zhang Y Cell Immunol; 2008; 253(1-2):102-9. PubMed ID: 18603231 [TBL] [Abstract][Full Text] [Related]
3. Growth-inhibitory effect of a novel synthetic triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, on ovarian carcinoma cell lines not dependent on peroxisome proliferator-activated receptor-gamma expression. Melichar B; Konopleva M; Hu W; Melicharova K; Andreeff M; Freedman RS Gynecol Oncol; 2004 Apr; 93(1):149-54. PubMed ID: 15047229 [TBL] [Abstract][Full Text] [Related]
4. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer. Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266 [TBL] [Abstract][Full Text] [Related]
5. Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin. Ghamande S; Hylander BL; Oflazoglu E; Lele S; Fanslow W; Repasky EA Cancer Res; 2001 Oct; 61(20):7556-62. PubMed ID: 11606394 [TBL] [Abstract][Full Text] [Related]
6. Expression of costimulatory molecules on human retinoblastoma cells Y-79: functional expression of CD40 and B7H1. Usui Y; Okunuki Y; Hattori T; Takeuchi M; Kezuka T; Goto H; Usui M Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4607-13. PubMed ID: 17003458 [TBL] [Abstract][Full Text] [Related]
7. CD40 is expressed on ovarian cancer cells and can be utilized for targeting adenoviruses. Hakkarainen T; Hemminki A; Pereboev AV; Barker SD; Asiedu CK; Strong TV; Kanerva A; Wahlfors J; Curiel DT Clin Cancer Res; 2003 Feb; 9(2):619-24. PubMed ID: 12576427 [TBL] [Abstract][Full Text] [Related]
8. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer. Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284 [TBL] [Abstract][Full Text] [Related]
9. Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers. Bakkum-Gamez JN; Aletti G; Lewis KA; Keeney GL; Thomas BM; Navarro-Teulon I; Cliby WA Gynecol Oncol; 2008 Jan; 108(1):141-8. PubMed ID: 17988723 [TBL] [Abstract][Full Text] [Related]
10. rIFN-gamma-mediated growth suppression of platinum-sensitive and -resistant ovarian tumor cell lines not dependent upon arginase inhibition. Melichar B; Hu W; Patenia R; Melicharová K; Gallardo ST; Freedman R J Transl Med; 2003 Sep; 1(1):5. PubMed ID: 14572312 [TBL] [Abstract][Full Text] [Related]
11. Strong cytotoxic effect of the bradykinin antagonist BKM-570 in ovarian cancer cells--analysis of the molecular mechanisms of its antiproliferative action. Jutras S; Bachvarova M; Keita M; Bascands JL; Mes-Masson AM; Stewart JM; Gera L; Bachvarov D FEBS J; 2010 Dec; 277(24):5146-60. PubMed ID: 21078129 [TBL] [Abstract][Full Text] [Related]
12. Direct and indirect effects of human recombinant gamma-interferon on tumor cells in a clonogenic assay. Saito T; Berens ME; Welander CE Cancer Res; 1986 Mar; 46(3):1142-7. PubMed ID: 3080233 [TBL] [Abstract][Full Text] [Related]
13. Reduced radiosensitivity and increased CD40 expression in cyclophosphamide-resistant subclones established from human cervical squamous cell carcinoma cells. Tanaka T; Bai T; Yukawa K; Utsunomiya T; Umesaki N Oncol Rep; 2005 Oct; 14(4):941-8. PubMed ID: 16142355 [TBL] [Abstract][Full Text] [Related]
14. Adenovirus delivery of human CD40 ligand gene confers direct therapeutic effects on carcinomas. Vardouli L; Lindqvist C; Vlahou K; Loskog AS; Eliopoulos AG Cancer Gene Ther; 2009 Nov; 16(11):848-60. PubMed ID: 19461675 [TBL] [Abstract][Full Text] [Related]
15. Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells. Wahl H; Tan L; Griffith K; Choi M; Liu JR Gynecol Oncol; 2007 Apr; 105(1):104-12. PubMed ID: 17174384 [TBL] [Abstract][Full Text] [Related]
16. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma]. Song Y; Shen K; Yu JR Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307 [TBL] [Abstract][Full Text] [Related]
17. Constitutive expression of functional CD40 on mouse renal cancer cells: induction of Fas and Fas-mediated killing by CD40L. Lee JK; Seki N; Sayers TJ; Subleski J; Gruys EM; Murphy WJ; Wiltrout RH Cell Immunol; 2005 Jun; 235(2):145-52. PubMed ID: 16213477 [TBL] [Abstract][Full Text] [Related]
18. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice. Itashiki Y; Harada K; Ferdous T; Yoshida H Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527 [TBL] [Abstract][Full Text] [Related]
19. Expression of the co-signaling molecules CD40-CD40L and their growth inhibitory effect on pancreatic cancer in vitro. He S; Zhao H; Fei M; Wu Y; Wang L; Zhu X; Li D Oncol Rep; 2012 Jul; 28(1):262-8. PubMed ID: 22552529 [TBL] [Abstract][Full Text] [Related]